Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

123.71 -2.72 (-2.15%)
Official Closing Price Updated: 8:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday? ↗
Kicking off the new month, Wall Street continued its strong November momentum, with major U.S. stocks rallying on Friday. 
Via Benzinga
Topics Economy
News headline image
Stocks Drift Higher On Stronger GDP Data, Oil Rebounds As OPEC+ Mulls Cuts: What's Driving Markets Wednesday? ↗
Stocks are experiencing their 16th green session out of the 20 so far in November, with the S&P 500 index reaching its highest level since early August, and the Nasdaq 100 just 4.4% below its all-time... 
Via Benzinga
News headline image
S&P 500, Nasdaq Slip As Tech Underperforms, Oil Reacts to OPEC+: What's Driving Markets Thursday? ↗
Thursday’s trading session on Wall Street presents a mixed picture, characterized by notable fluctuations in major indices. While tech-heavy benchmarks like the S&P 500 and the Nasdaq 100 are... 
Via Benzinga
Topics Stocks
News headline image
US Stocks Rebound As Treasury Yields, Dollar Fall On Dovish Fed Remarks, Gold Hits $2,040: What's Driving Markets Tuesday? ↗
U.S. stocks experienced a welcome resurgence on Tuesday, buoyed by the latest comments from Federal Reserve officials. 
Via Benzinga
Topics Economy
News headline image
Biotech And Healthcare Portfolio Playbook For December 2023/24 ↗
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January. 
Via Talk Markets
News headline image
Are You A Trader Or Investor: Biotech Momentum Is Picking Up ↗
ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market. 
Via Talk Markets
Topics ETFs
News headline image
3 Biotech Stocks That Could Boom or Bust by 2025 ↗
Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday. 
Via InvestorPlace
News headline image
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech ↗
Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic. 
Via Talk Markets
News headline image
This Week’s Data Dump May Lead To More Stock Market Pain ↗
This week will feature data that is not only going to move the markets, but also set the tone for fourth-quarter GDP growth. This means the dollar and rates will be more volatile, and the equity market... 
Via Talk Markets
News headline image
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy ↗
The market's dour reaction to Roivant Sciences' latest deal doesn't add up. 
Via The Motley Fool
News headline image
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield... ↗
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at... 
Via Talk Markets
Topics Economy
News headline image
Thoughts For Thursday: War Worries Rattle The Market ↗
Via Talk Markets
News headline image
Too Much To Handle For Stocks As Rates Continue To Rise ↗
Stocks finished sharply lower as rates reached new cycle highs on the long end of the curve, and the yield curve steepened. This led to a drop of about 1.3% on the S&P 500, bringing the index down to... 
Via Talk Markets
Topics Economy Stocks
News headline image
Stocks and Bonds Go Their Separate Ways ↗
Stocks were up today by around 1.1% on the S&P 500, but we have gone nowhere now in a week, so the bulls are making no progress. 
Via Talk Markets
Topics Stocks
News headline image
Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up ↗
Healthcare has not been a strong sector in 2023. Despite its history of being defensive in turbulent times the sector has underperformed as higher rates curb buyers sentiment. 
Via Talk Markets
News headline image
Stocks Rally And Rates Drop But Trends Remain In Place ↗
Stocks increased on Wednesday, rising by around 80 bps, as the dollar and rates fell. There is still a lot of data to come this week, with the Job report on Friday now front and center. 
Via Talk Markets
News headline image
Don’t Miss the Boom: 3 ETFs Set to Explode Higher ↗
The market may be uncertain. But these three ETFs to buy are set to deliver fantastic returns regardless of the broader economic climate. 
Via InvestorPlace
Topics ETFs
News headline image
Healthcare Playbook Revisited - Growth Plus Value ↗
Despite concerns about rising healthcare costs and ever more expensive technology for treatment encompassing drugs, devices, and data management, still innovative medicine marches on. 
Via Talk Markets
News headline image
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates ↗
These three pharma stocks could be driven higher amidst future revenue prospects as they report to investors positive clinical developments. 
Via InvestorPlace
News headline image
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug ↗
Calliditas, a rare disease company focused on kidney ailments, is optimistic of its lead drug taking off in a big way. 
Via Benzinga
News headline image
Healthcare Portfolio: A Mixed Market Looking for Value ↗
Many healthcare stocks may be defensive in nature but if you are overweight the basic plays like the XLV or biotech funds like the Fidelity Biotechnology Fund you are trailing the market over the past... 
Via Talk Markets
News headline image
Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio? ↗
It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months. 
Via Talk Markets
Topics ETFs
News headline image
If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now ↗
Roivant stock has outperformed the broader market and the biotech sector this year, mirroring the rise in the fortunes of its founder Vivek Ramaswamy. 
Via Benzinga
News headline image
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late ↗
Factors in the marketplace caused these companies to underperform, making them some of the top pharma stocks to sell. 
Via InvestorPlace
News headline image
5 Meme Stocks to Sell Immediately, According to AI ↗
As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks ↗
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%. 
Via Talk Markets
News headline image
3 Biotech Stocks to Buy for Long-Term Gains
The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors. 
Via MarketBeat
Topics ETFs Economy
News headline image
“The Secret To Happiness” Stock Market (And Sentiment Results) ↗
There’s an old maxim, “the secret to happiness is low expectations”. This saying could not apply more directly than to what we are seeing coming into the Q2 earnings season. 
Via Talk Markets
News headline image
Thoughts For Thursday: Back From The Holiday With Caution ↗
Caution is perhaps what was reflected in yesterday's back from the holiday trading. One there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China. 
Via Talk Markets
News headline image
Biotech Blues: Stay Balanced Through July Earnings Season ↗
Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.